Herpes symptoms are easy to miss and easy to misread, which is one reason many people carry the herpes simplex virus without ever knowing it. When they do appear, they are usually mild and short-lived, yet the diagnosis still carries more social weight than almost any other common infection. Much of that weight comes from confusion about testing: which test answers which question, and which results actually mean something. In this article you will learn how herpes symptoms look in a first episode and in recurrences, why a swab of an active sore is the most reliable test, what an antibody blood test can and cannot tell you, how episodic and suppressive therapy differ, and what changes during pregnancy.
What herpes is, and what it is not
Herpes is an infection caused by the herpes simplex virus, usually shortened to HSV. After the first infection, the virus travels along a nerve and settles in a cluster of nerve cells near the spine or the base of the skull, where it stays permanently in a quiet state called latency. From time to time it becomes active and travels back to the skin, with or without a visible sore. That cycle explains why herpes symptoms recur, why the infection cannot yet be cured, and why it spreads when nothing is visible.
HSV-1 and HSV-2 are virus types, not body sites
HSV-1 has traditionally been linked with cold sores around the mouth and HSV-2 with genital infection, but that split no longer holds. HSV-1 is now a frequent cause of first-episode genital herpes, especially in younger adults, and either type can infect either site. Knowing which type was found says something about the likely pattern of recurrences, but nothing about how or when the infection was acquired. A companion article explains the many causes of a blister on the lip.
How common it is
Reviews estimate that a majority of adults carry HSV-1 and roughly one in eight carries HSV-2, and most never receive a diagnosis because they never had recognizable herpes symptoms. A positive result places someone in a very large group.
Recognizing herpes symptoms
The classic description is a cluster of small fluid-filled blisters that break open, form a shallow ulcer, crust over and heal without scarring. Real life is less tidy. Many episodes look like a paper cut, a shaving nick, a single pimple, or a sore that stings only when urine touches it.
A first episode
The first episode is usually the most intense, because the immune system has not met the virus before. Alongside the sore, herpes symptoms at this stage often include fever, headache, body aches, tender lymph nodes and burning during urination. A first genital episode can last two to three weeks from the first tingle to full healing.
Recurrences
Recurrences are shorter, milder and more predictable. Many people notice a warning phase, called a prodrome, in the day before anything appears: tingling, itching, a shooting ache down the leg, or a spot of tenderness. The visible stage usually clears within a week. Recurrences are most frequent in the first year and then taper, especially with HSV-1 genital infection, which returns far less often than HSV-2.
When there are no symptoms at all
Most people with HSV-2 never had an episode they recognized as herpes. Some never develop lesions; others had signs mistaken for thrush or an ingrown hair. The absence of remembered herpes symptoms says little about whether someone carries the virus.
How the virus spreads
Herpes spreads through direct skin-to-skin or mucous-membrane contact: kissing, oral sex, vaginal sex and anal sex. It does not spread through toilet seats, towels, pools or shared drinks, because the virus survives poorly outside the body.
Shedding without symptoms
The key transmission concept is asymptomatic shedding: the virus periodically reaches the skin surface and can be passed on even when there is no sore and no sensation. Shedding is more frequent in the first year after infection, and with HSV-2 than HSV-1. It is why no strategy reduces risk to zero, and why people almost never transmit the virus knowingly.
Common triggers for a recurrence
Reactivation often follows an illness with fever, a stretch of poor sleep or heavy stress, strong sun exposure for oral lesions, local skin friction, hormonal changes around menstruation, or a medicine that weakens the immune system. Sometimes there is no identifiable trigger at all.
How herpes is diagnosed: why testing accuracy matters
Herpes is not one test with one answer, but two different questions answered by two different technologies.
If there is a sore, swab the sore
When a lesion is present, the preferred test is a swab of that lesion analyzed by a nucleic acid amplification test, usually a polymerase chain reaction assay. The laboratory looks for viral genetic material and reports whether it is HSV-1 or HSV-2. This is the only routine test that confirms an active infection at a specific site and moment. Readers who want the mechanics can consult a plain-language guide to RT-PCR testing.
Swab early, while the sore is still moist, because sensitivity falls as a lesion dries and crusts. A negative swab from a healing lesion does not rule out herpes; it may simply mean too little virus was present. Viral culture and antibody staining of a smear are being replaced, because both miss cases a molecular test finds.
Blood tests measure antibodies, not the sore
A type-specific serologic test looks for antibodies your immune system produced against HSV-1 or HSV-2. Blood testing measures immunoglobulin G antibodies, which appear weeks to months after infection and persist for life. That design creates four limitations worth knowing beforehand.
- Not when. Antibodies acquired fifteen years ago look identical to antibodies acquired last year.
- Not from whom, so it cannot settle a question about a current partner.
- Not where. A positive HSV-1 result far more often reflects childhood oral infection.
- Not reliably, near the threshold. Widely used HSV-2 assays give false positives at low index values, so a low positive needs a second, confirmatory method before anyone acts on it.
There is also a window period: testing too soon after an exposure can give a negative result in someone genuinely infected. Borderline numbers unsettle people who feel perfectly well, and we address abnormal blood test results in people who feel fine.
Why IgM testing is not recommended
Laboratories also report immunoglobulin M antibodies, which for many infections indicate recent exposure. For herpes they do not. HSV IgM assays are not type specific and can turn positive during an ordinary recurrence of an old infection, so a positive IgM is routinely misread as proof of a brand-new infection. National guidance is explicit that HSV IgM testing is not recommended; treat that line as noise rather than news. Some panels instead detect viral antigens in a sample, a third approach not used for genital herpes.
Why routine screening of people without symptoms is not advised
Herpes is deliberately left out of the standard sexually transmitted infection panel. In people who have never had herpes symptoms, a positive antibody result changes little medically, is wrong often enough at low index values to cause harm, and causes disproportionate distress. The CDC publishes detailed clinical guidance on genital herpes, and does not recommend serologic screening of the general population. Serology still has uses: recurrent ulcers with negative swabs, a partner of someone with known herpes, and some situations in pregnancy. Checkups more usefully include human papillomavirus screening alongside chlamydia, gonorrhea, syphilis and HIV testing, and other viral infections need different tools again; we describe the symptoms and testing of hepatitis B.
| Test | What it measures | Best used when | Main limitation |
|---|---|---|---|
| Lesion swab PCR or NAAT | Viral genetic material, plus the type | A blister, ulcer or fresh crust is present | Needs a lesion; sensitivity drops as it dries |
| Viral culture or antibody staining | Live virus or viral proteins | Rarely, mainly for resistance testing | Misses cases a molecular test finds |
| Type-specific IgG serology | Long-lasting antibodies to HSV-1 or HSV-2 | No lesion, and past exposure is the question | Silent on when, where and from whom; low positives need confirmation |
| HSV IgM serology | Early-response antibodies | Not recommended for herpes | Not type specific; often positive in old recurrences |
Treatment: episodic and suppressive antiviral therapy
Antiviral medicines do not remove the virus from nerve cells, so there is no cure yet. They limit viral replication during a reactivation, which shortens episodes, reduces pain and lowers the amount of virus reaching the skin. Three oral medicines are standard in the United States: acyclovir, valacyclovir and famciclovir, all inexpensive, well studied and well tolerated even over years of daily use.
Episodic therapy
Episodic therapy means keeping a short course on hand and starting it at the first sign of an episode, ideally during the prodrome. Started that early, it typically shortens the episode by a day or two; started after the blister has crusted, it does very little. Comfort measures help too: a sitz bath, loose cotton clothing and ordinary pain relief. Prescriptions written this way follow the rules of as-needed medication orders.
Suppressive therapy
Suppressive therapy means taking a lower dose every day, without waiting for herpes symptoms. It suits people with frequent or severe recurrences and people whose partner does not have the virus. National guidance describes a reduction of roughly seventy to eighty percent in recurrence frequency among people with frequent episodes, and daily therapy also lowers shedding between episodes. Dosing labels often use the twice-daily dosing abbreviation.
| Question | Episodic therapy | Suppressive therapy |
|---|---|---|
| When do you take it | Only at the first sign of an episode | Every day, whether or not symptoms appear |
| Who it suits | Rare or mild recurrences | Frequent recurrences, or a partner without the virus |
| Main benefit | Shorter, less painful episodes | Far fewer episodes and less shedding |
| Effect on a partner | Little measurable effect on transmission | Lowers the risk of passing the virus on |
Lowering the risk of passing herpes to a partner
No single measure eliminates risk, but they stack, and couples who combine them often go years without transmission.
- Avoid sexual contact from the first tingle until the last sore has healed and the skin is intact.
- Use condoms or dental dams between episodes, accepting that they cover only part of the skin that sheds virus.
- Consider daily suppressive therapy for the partner who has the virus, which measurably lowers transmission risk.
- Remember that oral sex during a cold sore can transmit HSV-1 to the genitals, now a common route of new genital infection.
- Tell partners before sex rather than after; a short, matter-of-fact sentence works better than an apology.
Herpes and pregnancy
Herpes in pregnancy is managed carefully, and the outcome is good in the large majority of cases. The concern is neonatal herpes, a rare but serious newborn infection, usually acquired during delivery through contact with virus in the birth canal rather than across the placenta.
Timing is the critical distinction. Risk is highest when a woman acquires a first infection late in pregnancy, because she has not yet made protective antibodies to pass to the baby, and much lower for a woman with long-standing herpes who has a recurrence at delivery. A recent review of maternal and fetal implications describes both patterns and notes that HSV-1 has become an important cause of neonatal disease.
Tell the obstetric team early about any history of herpes symptoms, in you or in your partner. Suppressive antiviral treatment is commonly started around thirty-six weeks in women with recurrent genital herpes, which reduces outbreaks at delivery and the need for cesarean delivery, and cesarean delivery is usually recommended if a lesion or prodrome is present when labor begins. If a partner has herpes and the pregnant person does not, condoms and no oral sex in the third trimester are reasonable precautions.
When to see a doctor
Most episodes are handled at home, but some deserve prompt medical attention.
- A first suspected episode, so a swab can be taken while it still gives a clear answer
- Sores near or in the eye, or eye pain with blurred vision, which needs same-day care
- Inability to urinate, or pain severe enough to prevent it
- Sores that spread, keep enlarging, or do not heal within about three weeks
- More than about six recurrences a year, which warrant a talk about suppressive therapy
- A weakened immune system from chemotherapy, transplant drugs, advanced HIV or steroids
- Pregnancy, particularly a new suspected infection or symptoms near the due date
- A newborn with blisters, poor feeding, floppiness or fever, which is an emergency
Living with the diagnosis
The medical footprint of herpes is small for most people, and the emotional footprint is often much larger. Three things help: the infection is extremely common, so a diagnosis says nothing about anyone’s character; recurrences usually become less frequent over the years; and effective, cheap treatment exists. It also helps to be careful about what a test result proves, because two people can each have a positive antibody test with no way to establish who acquired the virus first. Another virus in the same family causes infectious mononucleosis, and nobody assigns blame for that one.
Latest scientific advances
Research over the past three years has moved along two tracks: faster, more accurate diagnosis, and better drugs.
Testing is becoming more automated and more precise. A multicenter evaluation published in 2026 assessed an automated system that detects and distinguishes HSV-1, HSV-2 and the chickenpox virus from a single lesion swab, and it performed accurately across the sites that used it. What this means for you is that one swab can increasingly tell look-alike rashes apart in a single run. A separate 2026 comparison confirmed that molecular testing finds lesions an older staining method misses.
Antibody testing is being scrutinized more honestly. A 2024 study compared antibody results with molecular results in people whose genital herpes had already been confirmed by a swab, and found that antibody testing alone classified many of them incorrectly. The takeaway is concrete: a blood test is not a substitute for swabbing a sore. A 2025 evaluation of newer automated HSV antibody assays agreed, showing that results close to the positive threshold still disagree between platforms and still need a confirmatory method.
Point-of-care testing is close but not yet routine. Researchers described a rapid fingerstick device in 2026 that separates HSV-1 and HSV-2 antibodies outside a laboratory, and another 2026 group built a portable gene-editing panel that spots several sexually transmitted infections, including herpes, at the bedside. Both are early studies, so expect faster answers rather than different ones.
On treatment, a 2025 review summarized where drug development stands. The existing medicines all work the same way and can lose effectiveness in people with weakened immune systems, and a cure that clears the virus from nerve cells remains distant. The most promising newer class, helicase-primase inhibitors, attacks the virus by a different mechanism and may suppress it with less resistance, though that is still preliminary. Vaccines have repeatedly proved difficult, so the three established antivirals remain the practical answer.
Glossary
| Term | Definition |
|---|---|
| Herpes simplex virus (HSV) | The virus that causes herpes. Two types exist, HSV-1 and HSV-2, and either can infect the mouth or the genitals. |
| Latency | The quiet state in which the virus hides inside nerve cells between episodes. It is why the infection persists and why it can return. |
| Prodrome | The warning phase before a visible sore, felt as tingling, itching or a shooting ache. It is the best moment to start episodic treatment. |
| Asymptomatic shedding | Periods when the virus reaches the skin surface and can be passed on even though there is no sore and no sensation. |
| Nucleic acid amplification test (NAAT) | A laboratory method, usually a polymerase chain reaction assay, that copies and detects viral genetic material from a swab. |
| Type-specific serology | A blood test that identifies antibodies against HSV-1 or HSV-2 separately, rather than reporting herpes as a single result. |
| Index value | The number reported alongside a positive or negative antibody result. Values just above the cutoff are the least reliable and often need confirmation. |
| Immunoglobulin G (IgG) | A long-lasting antibody that appears weeks to months after infection and then stays for life. It shows past exposure, not current activity. |
| Immunoglobulin M (IgM) | An early-response antibody. For herpes it is unreliable, because it is not type specific and can rise during old recurrences. |
| Neonatal herpes | A rare but serious infection of a newborn, most often acquired during delivery. Risk is highest when the mother is newly infected late in pregnancy. |
Frequently asked questions
Is herpes curable?
Not yet. Antiviral medicines control the virus and reduce episodes, but they cannot remove it from the nerve cells where it rests between reactivations. Research into a cure continues, and newer drug classes look promising in early work, but nothing available today clears the infection. In practical terms, most people find that recurrences become less frequent over the years and that daily suppressive treatment, when they want it, keeps the condition close to invisible.
Is herpes dangerous?
For most healthy adults it is uncomfortable rather than dangerous. The infection stays in the skin and nerves and does not damage internal organs or shorten life. The situations that need more attention are infection in a newborn, infection involving the eye, and infection in someone whose immune system is significantly weakened by illness or medication. Those cases are uncommon and are treatable when identified early, which is the main reason to get an unusual or severe episode assessed rather than waited out.
Can herpes be transmitted with no symptoms present?
Yes. The virus periodically reaches the skin surface without producing a sore, a process called asymptomatic shedding, and transmission can happen during those periods. This is why most people who pass the virus on had no idea they were contagious at that moment. Consistent condom use and daily suppressive antiviral therapy both reduce the risk substantially, though neither removes it entirely. Avoiding sexual contact from the first warning sensation until the skin has fully healed remains the single most effective step.
How is herpes transmitted, and can it spread without sex?
It spreads through direct contact with infected skin or mucous membranes: kissing, oral sex, vaginal sex and anal sex. Non-sexual transmission happens too, most commonly when an adult with a cold sore kisses a child, which is how many people acquire HSV-1 in childhood. What does not transmit it is casual contact: toilet seats, towels, bedding, swimming pools, cutlery and shared drinks. The virus is fragile outside the body and does not survive on surfaces long enough to infect someone.
What causes an outbreak after years without one?
A long gap followed by a sudden episode is common and does not mean a new infection or a new partner. Reactivation is usually triggered by something that briefly shifts the immune system: an illness with fever, a period of heavy stress or poor sleep, surgery, strong sun exposure for oral lesions, hormonal changes, local skin friction, or a medication that suppresses immunity. Sometimes there is no identifiable trigger at all. A recurrence after many quiet years is a reactivation of a virus that has been present the whole time.
Should I ask for a herpes blood test if I have no symptoms?
Usually not, and it is deliberately excluded from routine sexually transmitted infection panels. In someone who has never had symptoms, an antibody result rarely changes medical care, is unreliable enough near the cutoff to produce false positives, and often creates distress out of proportion to the infection. There are exceptions worth discussing with a clinician: recurrent genital ulcers with negative swabs, being the partner of someone with known herpes, or certain circumstances in pregnancy or immune suppression. If you do test, ask for a type-specific test and ask for the index value.
Sources
- Centers for Disease Control and Prevention — Genital Herpes, STI Treatment Guidelines, 2021 (current clinical guidance) — https://www.cdc.gov/std/treatment-guidelines/herpes.htm
- MedlinePlus, National Library of Medicine — Genital Herpes — https://medlineplus.gov/genitalherpes.html
- Mayo Clinic — Genital herpes: diagnosis and treatment — https://www.mayoclinic.org/diseases-conditions/genital-herpes/diagnosis-treatment/drc-20356167
- Yao J, McElvania E, Al-Ghoul M, et al. — Multicenter clinical evaluation of a fully automated multiplex HSV-1, HSV-2, and VZV real-time PCR assay — Journal of Clinical Microbiology, 2026 — https://doi.org/10.1128/jcm.00535-26
- Rebmann DM, Bosshard PP — Utility of polymerase chain reaction and direct fluorescent antibody test for diagnosis of mucocutaneous herpes virus infection — Diagnostic Microbiology and Infectious Disease, 2026 — https://doi.org/10.1016/j.diagmicrobio.2026.117382
- Deng J, Ye YJ, Chen QP, et al. — Comparison of the accuracy of HSV1 and HSV2 antibody tests with PCR in the diagnosis of recurrent genital herpes — Clinical, Cosmetic and Investigational Dermatology, 2024 — https://doi.org/10.2147/CCID.S470020
- Bourdin J, Salmona M, Fidouh N, et al. — Evaluation of the analytical performances of the Alinity-i HSV-1 IgG and HSV-2 IgG chemiluminescent immunoassays — Journal of Clinical Virology, 2025 — https://doi.org/10.1016/j.jcv.2025.105776
- Vafai N, Chen S, Tong W, et al. — Type-specific antibody detection of herpes simplex virus types 1 and 2 in fingerstick blood at point-of-care sites by a rapid lateral flow immunochromatographic assay — Journal of Immunological Methods, 2026 — https://doi.org/10.1016/j.jim.2026.114083
- Low SJ, O’Neill MT, Fernando JA, et al. — CRISPR-Cas-based diagnostics for point-of-care detection of sexually transmitted infections: a laboratory development and evaluation study — The Lancet Microbe, 2026 — https://doi.org/10.1016/j.lanmic.2025.101289
- Silva Pereira S, Bussi Rosolen B, Almeida Duraes T, et al. — Maternal-fetal implications of herpes virus infection: an updated review — Diagnostics, 2026 — https://doi.org/10.3390/diagnostics16081147
- Birkmann A, Saunders R — Overview on the management of herpes simplex virus infections: current therapies and future directions — Antiviral Research, 2025 — https://doi.org/10.1016/j.antiviral.2025.106152
Further reading
- Understand lab results: reference ranges, flags and next steps
- The patient’s guide to AI lab interpretation
- Lab errors versus real emergencies: when to worry
- AI-powered blood test analyzer and translator
- Lupus: symptoms, causes and treatment options
Understand your lab results with BloodSense
A herpes report can be hard to read on your own, because the meaning depends entirely on which test was run: a swab of a sore, an IgG antibody test with an index value, or an IgM line that should not have been ordered at all. BloodSense reads your laboratory report in plain language and explains what each result does and does not establish, alongside the other tests that often appear on the same panel, such as antibody levels, liver enzymes or a full blood count. It helps you understand your results and prepare better questions; it does not diagnose you and does not replace your doctor.
